Company: ZVRA
Filing Date: 2025-03-11
Form Type: 8-K
Source: 0001437749-25-007032
Chunk: 2

Company: ZEVRA THERAPEUTICS, INC.
Filing Date: 2025-03-11
Form: 8-K
Item: Item 9.01
Chunk 2
---
Item 9.01

Financial Statements and Exhibits.

  (d)      Exhibits  

  Exhibit No.      Description                                                                  
         99.1      Press Release dated March 11, 2025.                                          
 ────────────────────────────────────────────────────────────────────────────────────────────────
          104      Cover Page Interactive Data File (embedded within the Inline XBRL document)  

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

                            Zevra Therapeutics, Inc.                                                               
  Date: March 11, 2025      By:                           /s/ Timothy J. Sangiovanni                               
                                                          Timothy J. Sangiovanni, CPA                              
                                                          Senior Vice President, Finance and Corporate Controller